ReviewIntegrated pharmacy research & practice2017
Preventing drug-related adverse events following hospital discharge: the role of the pharmacist.
Review in Integrated pharmacy research & practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials.BMC pharmacology & toxicology · 2019Pooled it
- Impact of clinical pharmacist involvement on emergency department physicians' work-time distribution: a comparative analysis.Therapeutic advances in drug safety · 2025Article
- Article
- Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting: a prospective observational study.International journal of clinical pharmacy · 2023Observational
- Exploring pharmacists' perspectives on preparing discharge medicine lists: A qualitative study.Exploratory research in clinical and social pharmacy · 2023Article
- Article
- Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2022Article
- The Future of Critical Care: Optimizing Technologies and a Learning Healthcare System to Potentiate a More Humanistic Approach to Critical Care.Critical care explorations · 2022Article
- Transit Care Hub pharmacist: improving patient flow within the hospital.International journal of clinical pharmacy · 2020Article
- The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication.International journal of environmental research and public health · 2020Review
- Assessment of Patients Misunderstanding of Dosing Instructions Among Outpatients in Dessie Referral Hospital, Northeast Ethiopia.Risk management and healthcare policy · 2020Article
- Self-Medication and Associated Factors Among Pregnant Women Attending Antenatal Care at Kemisie General Hospital, North East Ethiopia.Patient preference and adherence · 2020Article
- Rates and correlates of pharmacotherapy-related problems among psychiatric inpatients: a representative Danish study.Therapeutic advances in psychopharmacology · 2020Article
- Patient-Pharmacist Interaction in Ethiopia: Systematic Review of Barriers to Communication.Patient preference and adherence · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transition of care (ToC) points, and in particular hospital admission and discharge, can be associated with an increased risk of adverse drug events (ADEs) and other drug-related problems (DRPs). The growing recognition of the pharmacist as an expert in medication management, patient education and communication makes them well placed to intervene. There is evidence to indicate that the inclusion of pharmacists in the health care team at ToC points reduces ADEs and DRPs and improves patient outcomes. The objectives of this paper are to outline the following using current literature: 1) the increased risk of medication-related problems at ToC points; 2) to highlight some strategies that have been successful in reducing these problems; and 3) to illustrate how the role of the pharmacist across all facets of care can contribute to the reduction of ADEs, particularly for patients at ToC points.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.